ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,54
-2,74%
Bitcoin
57 792,79
-4,63%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Map Pharmaceuticals, Inc. (MM) (MAPP)

  7. Map Pharmaceuticals, Inc. (MM) (MAPP) Actualités

MAPP

Map Pharmaceuticals, Inc. (MM) (MAPP)

Map Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MAPP
DateHeureSourceTitreSymboleSociété
05/03/201318h38ZacksAllergan Reaches 52-Week High - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
04/03/201317h30ZacksAllergan - MAP Acquisition Update - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201323h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201323h23Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201323h21Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201322h01Edgar (US Regulatory)(25-NSE)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201321h54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201321h54Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201315h00Business WireAllergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
14/02/201320h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
14/02/201319h48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
07/02/201315h00Business WireAllergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201320h22Dow Jones NewsUPDATE: Strong Botox Sales Help Lift Allergan's Profits 16%NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201317h28ZacksAGN Earnings Miss but Guidance Tops - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201316h00Dow Jones NewsAllergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer ChargesNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201300h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/02/201319h08GlobeNewswire Inc.The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP PharmaceutNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/02/201317h50ZacksUpdate on AGN's Acquisition of MAP - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201322h20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201322h01Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201322h01Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201315h20PR Newswire (US)Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes DrugNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201315h00Business WireAllergan Commences Cash Tender Offer for All Outstanding Shares of MAP PharmaceuticalsNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201322h03Edgar (US Regulatory)(40-17F2)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201322h03Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201317h04Business WireFaruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201316h48PR Newswire (US)Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
29/01/201319h50ZacksFavorable Ruling for Allergan - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
26/01/201318h00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
25/01/201321h41PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmace...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:MAPP

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
EU
GLE
Societe Generale
EU
EN
Bouygues
COIN
ETHUSD
Ethereum
EU
RI
Pernod Ricard
NYSE
MCD
McDonalds
EU
PX4
SBF 120
NYSE
JPM
JP Morgan Chase
EU
PX1
CAC 40
EU
AI
Air Liquide
EU
HO
Thales
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
EU
VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés